Obstructive coronary artery disease Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting obstructive coronary artery disease clinical trials across 7 countries. Studies span Not Applicable, Phase 1. Top locations include Barcelona, Spain, Beijing, Beijing Municipality, China, Charlottesville, Virginia, United States. Updated daily from ClinicalTrials.gov.


Obstructive coronary artery disease Trials at a Glance

8 actively recruiting trials for obstructive coronary artery disease are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Barcelona, Beijing, and Charlottesville. Lead sponsors running obstructive coronary artery disease studies include China-Japan Friendship Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Baylor Research Institute.

Browse obstructive coronary artery disease trials by phase

Treatments under study

About Obstructive coronary artery disease Clinical Trials

Looking for clinical trials for Obstructive coronary artery disease? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Obstructive coronary artery disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Obstructive coronary artery disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

ANOCA - Angina With Non-obstructive Coronary ArteriesINOCA (Ischemia With Non Obstructive Coronary Artery Disease)
Baylor Research Institute50 enrolled1 locationNCT06896903
Recruiting

µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions

Obstructive coronary artery diseaseCoronary Artery DiseaseCoronary Artery Disease (Left Main)+1 more
Shanghai Zhongshan Hospital290 enrolled1 locationNCT07116083
Recruiting

SCORE-CUT DCB Trial: A Randomised Comparison of Scoring, Cutting, and Non-Compliant Balloon Lesion Preparation Strategies for Drug-Coated Balloon Angioplasty

Obstructive coronary artery disease
Sydney Local Health District198 enrolled2 locationsACTRN12625001349437
Recruiting
Phase 1

Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)

Coronary microvascular diseaseCoronary Microvascular Dysfunction (CMD)Angina Patients With Non-obstructive Coronary Artery Disease
University of Virginia150 enrolled1 locationNCT06600178
Recruiting
Not Applicable

Coronary Sinus Reducer in Patients With Angina With no Obstructive Coronary Disease

Angina With No Obstructive Coronary Artery DiseaseANOCACoronary Sinus Reducer
Medical University of Warsaw50 enrolled1 locationNCT07010029
Recruiting
Not Applicable

Imaging Coronary Microvascular Dysfunction (CMD) Study

Non obstructive coronary artery diseaseAngina
Icahn School of Medicine at Mount Sinai70 enrolled1 locationNCT05634031
Recruiting

Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)

Coronary Microvascular DysfunctionAngina Patients With Non-obstructive Coronary Artery DiseaseIndex of Microvascular Resistance
China-Japan Friendship Hospital100 enrolled1 locationNCT06503640
Recruiting

BIOmarkers and PLAtelet Function Assessment in Myocardial Ischemia and Non Obstructive Coronary Arteries Study

Ischemia With no Obstructive Coronary Artery Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS200 enrolled2 locationsNCT05714241